Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Bayer
AstraZeneca
GlaxoSmithKline
IDRx Inc. - A GSK Company
Turning Point Therapeutics, Inc.
Tempus AI
Theseus Pharmaceuticals
Hoffmann-La Roche
Aesculap AG
Mirror Biologics, Inc.
Takeda
Novartis
Pfizer
Exelixis
Poniard Pharmaceuticals
FeRx